Literature DB >> 8581146

Clinicopathologic study of primary gastric lymphoma of B cell phenotype with special reference to low-grade B cell lymphoma of mucosa-associated lymphoid tissue among the Japanese.

K Akaza1, T Motoori, S Nakamura, T Koshikawa, K Kitoh, N Futamura, T Nakamura, M Kojima, M Kuroda, M Kasahara.   

Abstract

Resection specimens from 83 patients with primary gastric lymphoma (PGL) of B cell phenotype at stage IE and at stage IIE according to the Ann Arbor classification were investigated. Histologically, these lymphomas could be divided into four types: Type I lesions (n = 24) were entirely made up of MALT lymphoma; Type II lesions (n = 13) were predominantly MALT lymphoma containing one to a few foci of high-grade B cell lymphoma; Type III lesions (n = 22) consisted largely of high-grade lymphoma with small areas of low-grade MALT lymphoma; and Type IV lesions (n = 24) were pure high-grade B cell lymphoma, mostly of the large cell type. All patients had undergone primary gastric resection, and 14 received additional chemotherapy (n = 12), or both chemotherapy and radiotherapy (n = 2). The survival probability was significantly higher for Types I and II lymphomas than for Types III and IV tumors (P < 0.05 by the generalized Wilcoxon test). According to The General Rules for the Gastric Cancer Study by the Japanese Research Society for Gastric Cancer, the stage of disease showed a clear distinction between each of them (P < 0.01 by the generalized Wilcoxon test). This staging method seemed to serve well as a prognostic indicator. The histological typing of the PGL of the present series also seemed to correlate with the gross appearance, pathologic stage and prognosis. Furthermore, the expression of cyclin D1, bcl-2 and p53 protein, and PCNA was immunohistochemically investigated in 42 cases of the present series. Most of the low-grade PGL (Types I and II) had less than 60% PCNA-positive cells, whereas the high-grade PGL (Types III and IV) had more than 60% positive cells. In a study for cyclin D1 protein, no cases showed the nuclear staining pattern characteristic for mantle cell lymphoma, and the cytoplasmic staining frequently observed in the node-based large B cell lymphoma was seldom identified in the PGL. This discrepancy might suggest a lineage difference among the morphologically similar, but site-different, lymphomas. On the other hand, bcl-2 protein overexpression was almost equal in frequency between the gastric and node-based high-grade B cell lymphomas. This is in contrast to the reports from Western countries, in which the majority of high-grade gastric tumors were bcl-2 negative.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581146     DOI: 10.1111/j.1440-1827.1995.tb03403.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

1.  Helicobacter-independent, chemotherapy-resistant, radiosensitive gastric MALT lymphoma with massive deposits of amyloidlike substance.

Authors:  Hiroshi Matsumoto; Hideki Koga; Mitsuo Iida; Hiroshi Suekane; Ken-Ichi Tarumi; Kazunori Hoshika; Yoshiki Mikami; Ken Haruma
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

2.  The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma.

Authors:  Y Kodera; Y Yamamura; S Nakamura; Y Shimizu; A Torii; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

3.  Survival outcomes and prognostic indicators for gastric cancer patients with positive peritoneal wash cytology but no peritoneal metastasis after radical gastrectomy.

Authors:  Wen-Zhe Kang; Yu-Xin Zhong; Fu-Hai Ma; Li-Yan Xue; Jian-Ping Xiong; Shuai Ma; Yang Li; Yi-Bin Xie; Xu Quan; Yan-Tao Tian
Journal:  World J Gastrointest Oncol       Date:  2021-01-15

4.  Correlation of Endoscopic Findings of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with Recurrence after Complete Remission.

Authors:  Chang Min Lee; Dong Ho Lee; Byung Kyu Ahn; Jae Jin Hwang; Hyuk Yoon; Young Soo Park; Cheol Min Shin; Nayoung Kim
Journal:  Clin Endosc       Date:  2016-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.